Page last updated: 2024-11-05

zonisamide and Citrullinemia

zonisamide has been researched along with Citrullinemia in 1 studies

Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.

Citrullinemia: A group of diseases related to a deficiency of the enzyme ARGININOSUCCINATE SYNTHASE which causes an elevation of serum levels of CITRULLINE. In neonates, clinical manifestations include lethargy, hypotonia, and SEIZURES. Milder forms also occur. Childhood and adult forms may present with recurrent episodes of intermittent weakness, lethargy, ATAXIA, behavioral changes, and DYSARTHRIA. (From Menkes, Textbook of Child Neurology, 5th ed, p49)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shaikh, AY1
Muranjan, MN1
Gogtay, NJ1
Lahiri, KR1

Other Studies

1 other study available for zonisamide and Citrullinemia

ArticleYear
Possible mechanism for zonisamide-induced hyperammonemia in a child with citrullinemia type 1.
    Indian journal of medical sciences, 2009, Volume: 63, Issue:5

    Topics: Anticonvulsants; Child; Citrullinemia; Humans; Hyperammonemia; Isoxazoles; Male; Seizures; Zonisamid

2009